David Akhavan, Ph.D.

Research Interests

-Cell-based immunotherapy targeting malignant brain tumors including Chimeric Antigen Receptor T Cells

- Molecular dissection of tumor antigen loss, T cell exhaustion, and cell manufacturing bottlenecks